Activities

We’ve created this area for COVID-19 information relevant to clinical trials. In line with the national guidance and emphasis on the safety and well-being of patients, research participants and their families, and health care professionals, researchers and other staff involved in patient care and research, ACTA strongly supports the continuation of investigator-led trials, where it is safe to do so, and with due consideration to any protocol amendments appropriate for the current COVID-19 pandemic.  

ACTA profiles its Members and the exceptional work they do in clinical trials and registries.

ACTA held a virtual workshop in May 2020 for key stakeholders to respond to and address the barriers to the uptake of registry randomised trials.…

Recent group activities: The Efficient and Effective Clinical Trial Networks Reference Group has been creating a suite of resources and tools for clinical trials networks,…

Recent group activities: The group has created resources for new clinical trials networks, now available in the resource area of this website. Establishment of New…

Recent group activities: Scope and definitions of the group were developed by leadership group early 2018Impact and Implementation forum held in August 2018 with national…

Recent group activities Consensus definition of embedding clinical trials in healthcareInternational Best Practice Towards a Learning Healthcare System: A scoping activity to map international approaches…

Recent group activities International Best Practice of Consumer Involvement in Research: Discussion PaperConsumer Involvement in Clinical Trials: Consultation ReportWorkshop: Consumer Involvement & Engagement Toolkit –…

Recent group activities An overview of medical research prioritisation for Clinical Trial NetworksA consultation survey of approaches and attitudes to prioritisation of clinical trials among…

Recent group activities: Most of the outputs for this group are academic and educational events. In early 2019 this reference group held a number of…

Recent group activities The group is also involved in academic and educational events—’Summer School’ events include:Registry-Randomised Trials Colloquium, one-day (ADE)Webinars held include:Data Linkage (1 of…

The executive committee of this group is very engaged and meets frequently to advance projects of this group. STInG has no activity funding, so the…

The Registries Special Interest Group is Chaired by Prof Stephen McDonald, ANZDATA Registry executive and renal physician, and its Board Sponsor is Prof John Zalcberg.…

ACTA is the peak body for clinical trial networks, clinical quality registries and clinical trial coordinating centres in Australia. We represent the investigator-initiated clinical trials…

SIGNet is ACTA’s Special Interest Group for Network Managers. Each Clinical Trial Network may nominate a representative on SIGNet. SIGNet provides a forum for Executive…